US0311621009
Impact Score
Amgen is a biotechnology firm that develops and manufactures innovative biologic medicines, focusing on oncology, cardiology, and nephrology.
Impact Score
Metric | Value | Unit | Year | PDF Name | PDF Page | |
---|---|---|---|---|---|---|
CEO-to-Employee Pay Ratio | ||||||
136 | ratio | 2023 | 0001193125-24-099062.pdf | 51 | ||
Robert A. Bradway | 2023 | dotherightthing.pdf | 4 | |||
Glass Ceiling | ||||||
53 | % | 2023 | amgen-2023-esg-report.pdf | 43 | ||
51 | % | 2023 | amgen-2023-esg-report.pdf | 43 | ||
Greenhouse Gas Emissions | ||||||
165 | 1,000 metric tons | 2023 | amgen-2023-esg-report.pdf | 34 | ||
26 700 | People | 2023 | amgen-2023-esg-report.pdf | 43 | ||
Harassment and Discrimination at the Workplace | ||||||
Yes | 2023 | dotherightthing.pdf | 29 | |||
Yes | 2023 | dotherightthing.pdf | 8 | |||
Yes | 2023 | dotherightthing.pdf | 15 | |||
Yes | 2023 | dotherightthing.pdf | 16 | |||
Renewable Energy | ||||||
1 091 | (1,000 gigajoules | 2023 | amgen-2023-esg-report.pdf | 34 | ||
3 001 | 1,000 GJ | 2023 | amgen-2023-esg-report.pdf | 43 | ||
Recycling and Recovery of Waste | ||||||
1 020 | (MT) | 2023 | amgen-2023-esg-report.pdf | 36 | ||
8 038 | (MT) | 2023 | amgen-2023-esg-report.pdf | 36 | ||
Women on the Board | ||||||
5 | People | 2023 | 0001193125-24-099062.pdf | 53 | ||
12 | People | 2023 | 0001193125-24-099062.pdf | 110 | ||
0 | People | 2023 | 0001193125-24-099062.pdf | 53 | ||
3 | People | 2023 | 0001193125-24-099062.pdf | 110 | ||
Women in Management | ||||||
51 | % | 2023 | amgen-2023-esg-report.pdf | 43 |